PharmaVOICE Podcasts

Transitioning Clinical Trial Patients to Commercial Supply via Managed Access Programs


Listen Later

This podcast describes how Managed Access Programs can continue treatment access for patients coming out of registration or other clinical trials who need to transition to commercial supply. Thought Leaders: Suzanne Gagnon, MD, Chief Medical Officer, Idis, Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development and Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development Play podcast
...more
View all episodesView all episodes
Download on the App Store

PharmaVOICE PodcastsBy Daniel Limbach